rs145131801
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_020699.4(GATAD2B):c.1469C>T(p.Ala490Val) variant causes a missense change. The variant allele was found at a frequency of 0.00616 in 1,613,156 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0043 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0063 ( 38 hom. )
Consequence
GATAD2B
NM_020699.4 missense
NM_020699.4 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 4.97
Publications
13 publications found
Genes affected
GATAD2B (HGNC:30778): (GATA zinc finger domain containing 2B) This gene encodes a zinc finger protein transcriptional repressor. The encoded protein is part of the methyl-CpG-binding protein-1 complex, which represses gene expression by deacetylating methylated nucleosomes. Mutations in this gene are linked to intellectual disability and dysmorphic features associated with cognitive disability. [provided by RefSeq, Jun 2016]
GATAD2B Gene-Disease associations (from GenCC):
- severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Illumina, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0066090226).
BP6
Variant 1-153812083-G-A is Benign according to our data. Variant chr1-153812083-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 211066.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 658 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GATAD2B | NM_020699.4 | c.1469C>T | p.Ala490Val | missense_variant | Exon 9 of 11 | ENST00000368655.5 | NP_065750.1 | |
| GATAD2B | XM_047426115.1 | c.1472C>T | p.Ala491Val | missense_variant | Exon 9 of 11 | XP_047282071.1 | ||
| GATAD2B | XM_047426117.1 | c.1469C>T | p.Ala490Val | missense_variant | Exon 9 of 11 | XP_047282073.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GATAD2B | ENST00000368655.5 | c.1469C>T | p.Ala490Val | missense_variant | Exon 9 of 11 | 1 | NM_020699.4 | ENSP00000357644.4 |
Frequencies
GnomAD3 genomes AF: 0.00432 AC: 658AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
658
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00464 AC: 1166AN: 251342 AF XY: 0.00461 show subpopulations
GnomAD2 exomes
AF:
AC:
1166
AN:
251342
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00635 AC: 9275AN: 1460872Hom.: 38 Cov.: 30 AF XY: 0.00603 AC XY: 4386AN XY: 726784 show subpopulations
GnomAD4 exome
AF:
AC:
9275
AN:
1460872
Hom.:
Cov.:
30
AF XY:
AC XY:
4386
AN XY:
726784
show subpopulations
African (AFR)
AF:
AC:
33
AN:
33458
American (AMR)
AF:
AC:
106
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
20
AN:
26130
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
7
AN:
86238
European-Finnish (FIN)
AF:
AC:
266
AN:
53380
Middle Eastern (MID)
AF:
AC:
30
AN:
5592
European-Non Finnish (NFE)
AF:
AC:
8518
AN:
1111294
Other (OTH)
AF:
AC:
295
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
413
826
1238
1651
2064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
324
648
972
1296
1620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00432 AC: 658AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.00398 AC XY: 296AN XY: 74464 show subpopulations
GnomAD4 genome
AF:
AC:
658
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
296
AN XY:
74464
show subpopulations
African (AFR)
AF:
AC:
48
AN:
41542
American (AMR)
AF:
AC:
51
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5192
South Asian (SAS)
AF:
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
AC:
28
AN:
10608
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
513
AN:
68032
Other (OTH)
AF:
AC:
11
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
33
66
99
132
165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
30
ALSPAC
AF:
AC:
20
ESP6500AA
AF:
AC:
11
ESP6500EA
AF:
AC:
63
ExAC
AF:
AC:
632
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 26, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
GATAD2B: BS2 -
not specified Benign:1
May 08, 2014
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;.
REVEL
Benign
Sift
Benign
T;.;.
Sift4G
Benign
T;T;T
Polyphen
P;P;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.